This practitioner-oriented Master’s degree provides students with a practical and theoretical foundation for successful careers in risk management, compliance, regulation and allied work streams within the financial services industry. Skills are developed through creating a broader understanding of financial firm risk-taking, accountability, governance.
The emphasis is on a deep analysis of mainstream and critical authorship. We will challenge current and past thinking on the role of financial institutions and markets. The programme particularly encourages students to examine regulatory structures and concepts in the context of recent and past financial crises.
Students will build the skills and knowledge needed to gain an understanding of financial reform processes and their consequences for markets around the world. Rigorous classroom teaching coupled with extensive reading provides students with a sound theoretical basis. An understanding of substantive legal issues is also developed.
Contributions by industry and regulatory experts introduces students to the nuances of real world application of theoretical constructs. Practical case studies, current legal positions and interactive student discussions or presentations are used in most lectures. In addition legal, academic, practitioner and regulatory input is gained through specialist guest lectures and visits as per the ability of the year-group.
Some key topics taught within this degree include:
October – December: Part 1 Autumn Term
January: Part 1 Exams
January-April: Part 2 Spring Term
May – June: Part 2 Exams
June – August (12 month programme only): Part 3
August/Sep (12 month programme only): Part 3 Coursework deadlines
Part 1 compulsory modules
Part 2 compulsory modules
Part 3 optional modules
Students on the 12-months programme should choose one from the following:
Full-time: 9 months Full-time: 12 months
Students will be resident and undertake full-time study in the UK. Under both, the 9 and 12-month programmes students take compulsory and/or elective modules in Part 2.
The 12 month option involves taking an elective 20 credit module between July and August, which would also mean a 20 credit reduction in the number of taught modules taken in the spring term.
The financial services sector has an ever-expanding need for graduates trained in the fundamentals of compliance, governance and regulation. This increasing demand has been fuelled by implementation of a number and rules and laws, including the EU Market Abuse Directive, Markets in Financial Instruments (MiFID), global standards such as Basel II, and the FSA and US regulators’ focus on principles-based regulation, all of which require significant in-house compliance resources.
With recent explosive growth in capital markets such as China,India, the Middle East and Eastern Europe, combined with the increasing complexity of financial products and a growing sophistication on the part of investors and market participants, there are immense challenges facing institutions, compliance professionals within them and regulators.
Our graduates are in a very strong position to build successful careers in the compliance or legal divisions of investment banks, fund managers and hedge funds, retail banking institutions and other market participants.
The ICMA Centre is a Chartered Institute of Securities and Investment (CISI) Centre of Excellence. Centres of Excellence are a select group of UK universities, recognised by the CISI as offering leadership in academic education on financial markets. Students who are on a financially-related masters course recognised by the CISI are eligible for exemptions and membership.
ICMA Centre students who register and successfully complete two CISI Diploma in Capital Markets modules (Securities and Bonds & Fixed Interest Markets) are eligible for an exemption from the third module (Financial Markets).
ICMA Fixed Income Certificate
To obtain the requisite knowledge to pass the rigorous FIC exam, students are required to take the ICMA Centre Fixed Income Cash and Derivatives Markets module at Part 2. In order to receive the FIC certificate, students will need to register and pass the FIC exam through ICMA.
This course increases your knowledge and skills in pharmacology and biotechnology to increase your competitiveness in the job market or complete research at PhD level. If you are already employed, this course can help you to further your career prospects.
The course is delivered by internationally recognised academics who are involved in biotechnology and pharmacology research. Research projects include studying the manipulation of proteins and their application to Alzheimer's disease, epilepsy, ion channels and the development of novel drugs from natural products.
You learn in detail how drugs act at the molecular and cellular level and then how biotechnological techniques are used to produce new drugs. Examples include developing new and effective treatments for diseases, such as Alzheimer’s and rheumatoid arthritis.
You also gain experience of the latest techniques used by the pharmaceutical industry to produce and study the effects of novel drugs.
The course gives you
The masters (MSc) award is achieved by successfully completing 180 credits.
The postgraduate certificate (PgCert) is achieved by successfully completing 60 credits.
The postgraduate diploma (PgDip) is achieved by successfully completing 120 credits.
Assessment is mostly by written examination and coursework including problem solving exercises, case studies and input from practical laboratory work. Research project assessment includes a written report and viva voce.
The course improves your career prospects in areas of • biomedical sciences • medical research in universities and hospitals • the pharmaceutical industry • biotechnology companies • government research agencies.
You also develop the skills to carry out research to PhD level in pharmacology and biotechnology.
Recent MSc Pharmacology and Biotechnology graduates jobs include • project specialist at PAREXEL • quality assurance documentation assistant at Vifor Pharma • PhD at the University of Manchester • clinical research associate at AstraZeneca • workplace services analyst at Deloitte India (Offices of the US) • regulatory compliance specialist for Selerant • senior product executive at PlasmaGen BioSciences.